Featured Product Description
Tests
Information
OncoIndx™ offers Comprehensive Genomic Profiling (CGP) across all Solid Tumors. It is a well-validated NGS test to extract therapy information from both tissues as well as blood samples with a Faster Turn Around Time of less than 15 days.
Test Highlights
1000+ Genes: Covers over 1000 targetable or therapeutically significant genes.
High Coverage: Achieves >99% on-target coverage to ensure comprehensive analysis.
Mean Depth: With depths of 2000x for tissue and 10000x for blood samples, we ensure thorough examination.
Genomic Markers Covered
300 Resistance Markers
50 Translocations (fusions)
Genome-wide CNV backbone
Genome-wide LOH markers
47 HRR genes
Genome-wide HRD scoring (based on an aggregate of LOH, LST, TAI and HRR)
MSI (including 2000 MSI and MMR genes)
18 Pharmacogenomic markers
TMB (Tumor Mutational Burden)
What sets us apart?
Longitudinal monitoring markers
Traceability to ongoing clinical trials worldwide
PD-L1 through IHC (TBx) / immunofluorescence on CTCs (LBx) CTC enumeration
